Kaiser Clinic and Hospital
12
3
3
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Autologous SVF Therapy for Type 2 Diabetes
Role: lead
Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome
Role: lead
Endoscopic Treatment of Overweight and Mild Obesity with ORBERA365
Role: lead
SUPPLEMENTATION WITH BETA GLUCAN AND ADAPTATIVE RESPONSE.
Role: collaborator
Systemic Metabolic Rate of Diabetic Patients Before and After Bariatric Gastric Bypass Using the Breezing® Device.
Role: lead
Carbon Dioxide Versus Air Insufflation for the Application of Argon Plasma to Reduce the Gastrojejunal Anastomosis
Role: lead
Evaluating the Efficacy and Results of Endoscopic Gastroplasty Performed Using Overstitch in Patients With Obesity.
Role: lead
Efficacy and Results of Endoscopic Gastroplasty Using Overstitch in Patients With Class I and II Obesity
Role: lead
Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons in the Treatment of Obesity
Role: lead
Endoscopic Argon Plasma Coagulation Vs. Control For Weight Regain After Gastric Surgery
Role: lead
Preoperative and Postoperative Endoscopic Alterations in Patients Submitted to Gastric Bypass Without a Ring
Role: lead
Aquanet Bowel Cleansing Device Versus Oral Sodium Picosulfate for Pre-endoscopy Bowel Preparation
Role: lead
All 12 trials loaded